165 related articles for article (PubMed ID: 37212653)
1. Contribution of Iron-Transport Systems and β-Lactamases to Cefiderocol Resistance in Clinical Isolates of Acinetobacter baumannii Endemic to New York City.
Asrat H; Samaroo-Campbell J; Ata S; Quale J
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0023423. PubMed ID: 37212653
[TBL] [Abstract][Full Text] [Related]
2. Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii.
Poirel L; Sadek M; Nordmann P
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0087721. PubMed ID: 34252309
[TBL] [Abstract][Full Text] [Related]
3. First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria.
Strateva T; Peykov S
Acta Microbiol Immunol Hung; 2024 Mar; 71(1):25-36. PubMed ID: 38261035
[TBL] [Abstract][Full Text] [Related]
4. Activity of Cefiderocol Against
Iregui A; Khan Z; Landman D; Quale J
Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan.
Yamano Y; Ishibashi N; Kuroiwa M; Takemura M; Sheng WH; Hsueh PR
J Glob Antimicrob Resist; 2022 Mar; 28():120-124. PubMed ID: 34958997
[TBL] [Abstract][Full Text] [Related]
6. Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3.
Malik S; Kaminski M; Landman D; Quale J
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868330
[TBL] [Abstract][Full Text] [Related]
7. Role of transcriptomic and genomic analyses in improving the comprehension of cefiderocol activity in
Stracquadanio S; Nicolosi A; Privitera GF; Massimino M; Marino A; Bongiorno D; Stefani S
mSphere; 2024 Jan; 9(1):e0061723. PubMed ID: 38078714
[TBL] [Abstract][Full Text] [Related]
8. Acinetobacter baumannii response to cefiderocol challenge in human urine.
Nishimura B; Escalante J; Tuttobene MR; Subils T; Mezcord V; Pimentel C; Georgeos N; Pasteran F; Rodriguez C; Sieira R; Actis LA; Tolmasky ME; Bonomo RA; Ramirez MS
Sci Rep; 2022 May; 12(1):8763. PubMed ID: 35610334
[TBL] [Abstract][Full Text] [Related]
9.
Mushtaq S; Sadouki Z; Vickers A; Livermore DM; Woodford N
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958717
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
[TBL] [Abstract][Full Text] [Related]
11. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
[TBL] [Abstract][Full Text] [Related]
12. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii.
Liu X; Lei T; Yang Y; Zhang L; Liu H; Leptihn S; Yu Y; Hua X
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0082822. PubMed ID: 36377939
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
15. Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence.
Kollef M; Dupont H; Greenberg DE; Viale P; Echols R; Yamano Y; Nicolau DP
Int J Antimicrob Agents; 2023 Aug; 62(2):106882. PubMed ID: 37301312
[TBL] [Abstract][Full Text] [Related]
16. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
17. Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.
Said HS; Benmahmod AB; Ibrahim RH
World J Microbiol Biotechnol; 2018 Dec; 34(12):189. PubMed ID: 30511216
[TBL] [Abstract][Full Text] [Related]
18. Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care Unit.
Smoke SM; Brophy A; Reveron S; Iovleva A; Kline EG; Marano M; Miller LP; Shields RK
Clin Infect Dis; 2023 Feb; 76(3):e1261-e1265. PubMed ID: 35974429
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Biglari S; Hanafiah A; Mohd Puzi S; Ramli R; Rahman M; Lopes BS
Microb Drug Resist; 2017 Jul; 23(5):545-555. PubMed ID: 27854165
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial spectrum of cefiderocol.
Gijón Cordero D; Castillo-Polo JA; Ruiz-Garbajosa P; Cantón R
Rev Esp Quimioter; 2022 Sep; 35 Suppl 2(Suppl 2):20-27. PubMed ID: 36193981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
